Simos Symeonidis
Simos Symeonidis is a co-founder of Kos Biotechnology Partners, an international investment fund focused on biotechnology and pharmaceutical technologies. The fund aims to manage €120 million initially, with plans to increase it to €150 million, targeting advancements in drug-related technologies.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Greece | 1 | 5.00 | 0.07% | +0% | 10,423,054 | 7,129 | $190,000 | 130$ |
| Totals | 1 | 10,423,054 | 7,129 | $190,000 | 130$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Greece:
Simos Symeonidis highlighted the serious risks posed by changes in funding and staffing at NIH and FDA.
5
Greece:
Simos Symeonidis is a doctor and co-founder of Kos Biotechnology Partners, an investment fund focusing on biotechnology.
8